Introduction
The association between high blood cholesterol concentrations and a person's risk ofcoronary heart disease is now widely accepted. The relation at lower concentrations has been-harder to assess, because the shallower gradient and lower incidence call for exceptionally large studies. The question is, however, of great -importance in terms of the possible benefits ofdietary advice to the population. In the Whitehall study plasma cholesterol concentration was measured in a large group of men whose mortality has now been followed up for over 10 years; this provided enough data for us to explore this question. 
Methods
Data were available on 17 718 male civil servants aged 40-64 in London.' 2 Plasma cholesterol concentration at entry to the study was measured on a capillary blood sample, using the then standard Technicon method N24a; it is now suspected that the readings may have been about 10% too low, and so the results are presented here within deciles or quintiles. The quintile points (uncorrected) were 4-11, 4 75, 5-27, and 6 05 mmol/l (159, 184, 204, and 234 mg/lOOml). Concentrations were not significantly related to age. Recording of deaths was virtually complete owing to the help of the National Health Service Central Registry. During the first 10 years 703 men died ofcoronary heart disease (International Classification ofDiseases (eighth revision) codes 410 414). Table I shows mortality from coronary heart disease at 10 years within deciles and quintiles of plasma cholesterol concentration. There was a clear and highly significant trend over the whole range of concentrations, some small irregularities being well within sampling limits. The slope of the fitted linear regression corresponded to a change of 0-64 deaths from coronary heart disease/100 men/10 years for a change in cholesterol concentration of 1 mmol (38-7 mg), with no significant departure from a linear trend. An optimal lower concentration could not be established: within the range observed the lower the concentration the better, as mortality associated with concentrations in the lowest tenth of the distribution was 90/o lower than that associated with concentrations in the next lowest-tenth.
Results
If the mortality among all the men had been the same as that among the men whose concentrations were below the lowest decile then 482 rather than 703 deaths from coronary heart disease would -have been expected, a reduction of 221 (31%). This underestimates the true proportion of deaths from coronary heart disease attributable to cholesterol for two reasons. Firstly, it was not possible to establish the optimum -plasma cholesterol concentration, relative to which the excess of deaths from coronary heart disease related to cholesterol could be measured, as the real "minimum risk" category seemed to be below that of the lowest tenth in the study. Secondly, as the cholesterol concentration was measured only once gradients at both extremes would have been underestimated because of the effects of random error and regression to the mean.
The final columns of table I show the best estimates of the distribution of the deaths attributable to cholesterol. Such deaths were spread over the whole range of cholesterol concentrations, with 55% arising in the middle of the distribution (between the first and fourth quintiles). Roughly one quarter were associated with concentrations above-the top decile, and 43% with concentrations above the top quintile. The high proportion of attributable deaths at the top end of the distnbution of concentrations was somewhat exagrated because of the underesimate of total attributable cases (see above), but this exaggeration was balanced by the underestimation resulting from regression to the mean. Analysis ofthe relation between mortality from coronary heart disease and cholesterol concentration by age (table II) showed that the relative increase in the risk of fatal coronary heart disease with rising cholesterol concentration got sigifntly less with advancing age but that the absolute increase in risk tended to get larger (though not significantly so), being 0*50/o/l years/mmol cholesterol/i in men aged 40-44 and 1-30/o/0 years/mmol cholesterol/l in men aged 60-4.
The data in table I were used to estimate the relative potentials of two intervention policies. If men with cholesterol concentrations in the top fifth of the distribution were identified by screening and treated so that their mortality was reduced to that in men with concentrations in the next fifth (corresponding to a reduction in cholesterol concentration of about 18%) then expected deaths at 10 years in this group would fall by 17% (fromJ94-to 160). This implies that for 1000 men screened and 200 treated roughly two deaths from coronary heart disease might be prevented over 10 years-that is, about 5% of the total deaths from coronary heart disfase. Ifonly the men with concentrations in the top tenth ofthe distribution were treated and their. risk reducedto thatof the men in the next tenth, the theoretical expected fall in total deaths from coronary heart diease would be 3%. (In practice it would be much less, because ofincomplete detection and compliance.)
A different approach would be to lower all cholesterol concentrations in the population. We estimate from our data that a reductionby the equivalent of one decile (about 8%o), with a corresponding fall in riskl, would reduce deaths from coronary heart disease at 10 years by 8% (from about 40 to 36/1000 population).
These theoretical benefits are underestimates because of the errors assocated with using a single measurement ofcholesterol concentration, but the relative potentials of the two policies can be compared with more Discussion Ideas of "norma" blood cholesterol concentrations date back to the laboratory practice ofdefining normality in terms ofa range (for example, ±2 SD) around the population average. This has led to the mistaken view that what is normal in the sense ofcommon is also normal in the sense of good. Comparisons between populations, however, have shown remarkable shifts in the whole distribution of risk variables,3 so that a blood cholesterol concentration that might be regarded as low in Finland would be considered high in Japan. In the case of blood pressure it is now recognised that the risk of heart attack shows a graded relation over the whole range of values, subjects with pressures in the middle of the distribution having a greater risk than those with low pressures; as subjects with pressures in the middle of the range are so numerous, they in fact generate more cases than the less common subjects with hypertension.4 Recent evidence from the population screened in the American multiple risk factor intervention trial showed that in this respect there is a close analogy between blood pressure and serum cholesterol concentration.5 For the first time the number of subjects studied was adequate for the risk of coronary heart disease in subjects with cholesterol concentrations in the miiddle and lower parts of the range to be examined. From this five year follow up of 361 000 men it became clear that at least 800/o of the American population had too high a concentration in terms of their risk of a fatal heart attack. The same finding has now emerged from the Whitehall study. Thus, biologically speaking, few people in Western countries have a "normal" blood cholesterol concentration: the primary lipid problem underlying mass coronary heart disease should be seen as a population average that is too high, which then aggravates a secondary problem for those deviant individuals with hypercholesterolaemia.
The data from the Whitehall study permitted estimates of the potential benefits ofvarious preventive approaches. The "high risk" strategy, exemplified by the Lipid Research Clinics programme, concentrates on detecting and treating those with concentrations in the upper segment of the distribution.' Our data suggest that perhaps a quarter of the burden of coronary heart disease related to cholesterol in the United Kingdom arises in people with cholesterol concentrations above the top decile of the distribution, indicating that they are a potentially important target for control efforts. Regardless of whether or not such efforts are worth while for the individual people concerned, however, the benefit to the population as a whole turns out to be small.
The population approach to prevention seeks to lower the unacceptably high average cholesterol concentration in the population as a whole. The data reported here imply that the potential benefit of such a policy is substantially greater than that of the high risk strategy. Most of the benefit would be seen in people with concentrations in the top half of the distribution, but some benefit would probably be seen even in those with below average values.
Thus even a small decrease in the population's average cholesterol concentration could achieve much more than a policy of screening for and treating hypercholesterolaemia. Nevertheless, screening for hypercholesterolaemia can make some contribution, as well as being important for the subjects concemed.
